Holen Sie sich die Stockscreener-App
2.43
3.19%
-0.08
Handel nachbörslich:
2.41
-0.02
-0.82%
Exagen Inc Aktie (XGN) Neueste Nachrichten
Exagen to Announce Third Quarter 2024 Results on November 12, 2024 - GlobeNewswire
Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence - The Manila Times
Renaissance Technologies LLC Boosts Holdings in Exagen Inc. (NASDAQ:XGN) - Defense World
Exagen Insider Stock Sales Prove Timely As Market Valuation Descends To US$47m - Simply Wall St
Stonepine Capital Management LLC Has $653,000 Holdings in Exagen Inc. (NASDAQ:XGN) - Defense World
Exagen Inc. (NASDAQ:XGN) Shares Sold by Nantahala Capital Management LLC - Defense World
Exagen's SWOT analysis: diagnostic firm's stock poised for growth amid challenges - Investing.com
Exagen Inc. (NASDAQ:XGN) Short Interest Up 20.9% in September - MarketBeat
Octopus Energy acquires solar and storage company Exagen Group - Yahoo Finance
Octopus buys British solar and battery storage firm Exagen - Reuters
PARP Inhibitor Biomarkers Market Expected to Reach $1.75 Billion by 2031 - WhaTech
Autoimmune Disease Diagnostics Market 2024 Global Insights and Business Scenario 2031 - Newstrail
San Diego 2024 Top Tech Awards ceremony set for Sept. 26 at Snapdragon Stadium - CBS News 8
Autoimmune Disease Testing Market to Reach $12.1 Billion, Globally, by 2033 at 8.6% CAGR: Allied Market Research - PR Newswire UK
Bears are Losing Control Over Exagen (XGN), Here's Why It's a 'Buy' Now - MSN
Shareholders in Exagen (NASDAQ:XGN) have lost 84%, as stock drops 12% this past week - Yahoo Finance
PARP Inhibitor Biomarkers Market to Surge with 8.8% CAGR by 2031 - WhaTech
Improved Revenues Required Before Exagen Inc. (NASDAQ:XGN) Stock's 40% Jump Looks Justified - Simply Wall St
Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference - ForexTV.com
Exagen Inc. (NASDAQ:XGN) Short Interest Down 41.5% in August - MarketBeat
Short Interest in Exagen Inc. (NASDAQ:XGN) Decreases By 41.5% - Defense World
Exagen (XGN) Shows Fast-paced Momentum But Is Still a Bargain Stock - Yahoo Finance
Matthew G. Brown - Wilson Sonsini
Detailed Analysis of Personalized Medicine Market Exploring Future Growth Potential, New Developments, Comp... - WhaTech
XGN (Exagen) EBITDA : $-13.05 Mil (TTM As of Jun. 2024) - GuruFocus.com
XGN (Exagen) Debt-to-EBITDA : -3.02 (As of Jun. 2024) - GuruFocus.com
XGN (Exagen) Net Income From Continuing Operations : $-17.31 Mil (TTM As of Jun. 2024) - GuruFocus.com
XGN (Exagen) Profitability Rank : 2 (As of Jun. 2024) - GuruFocus.com
XGN (Exagen) Revenue : $56.66 Mil (TTM As of Jun. 2024) - GuruFocus.com
XGN (Exagen) EBITDA per Share : $-0.73 (TTM As of Jun. 2024) - GuruFocus.com
XGN (Exagen) Net-Net Working Capital : $0.09 (As of Jun. 2024) - GuruFocus.com
XGN (Exagen) Earnings Yield % : N/A% (As of Aug. 19, 2024) - GuruFocus.com
Reviewing Exagen (NASDAQ:XGN) and BioNexus Gene Lab (NASDAQ:BGLC) - Defense World
Investing in Exagen Inc (XGN) Is Getting More Attractive - Knox Daily
Personalized Medicine Market to Reach US$ 1,078.17 Billion - GlobeNewswire
Exagen Inc. (XGN) Soars to 52-Week High, Time to Cash Out? - MSN
SOLVD Health Names Chief Financial Officer and Senior Vice President of Clinical Operations - Business Wire
Hyper Personalized Medicine Market Recovery and Impact Analysis Report – Dako A/S, Exagen Inc., Abbott - TIMC
Exagen stock touches 52-week high at $2.75 amid market fluctuations - Investing.com
Cantor Fitzgerald Research Analysts Lift Earnings Estimates for Exagen Inc. (NASDAQ:XGN) - Defense World
Fast-paced Momentum Stock Exagen (XGN) Is Still Trading at a Bargain - MSN
Q3 2024 EPS Estimates for Exagen Inc. Lifted by Analyst (NASDAQ:XGN) - Defense World
Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates - MSN
Exagen Inc (XGN) Q2 2024 Earnings Call Transcript Highlights: Re - GuruFocus.com
Analyst Estimates: Here's What Brokers Think Of Exagen Inc. (NASDAQ:XGN) After Its Second-Quarter Report - Simply Wall St
Exagen (NASDAQ:XGN) Releases Quarterly Earnings Results, Beats Estimates By $0.20 EPS - Defense World
Exagen Inc. (NASDAQ:XGN) Q2 2024 Earnings Call Transcript - Insider Monkey
Exagen (NASDAQ:XGN) Issues Quarterly Earnings Results - American Banking and Market News
Earnings call: Exagen Inc. reports improved financials, upgrades AVISE CTD - Investing.com
XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q2 2024 - InvestorPlace
Exagen, Inc. (XGN) Q2 2024 Earnings Call Transcript - Seeking Alpha
2.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):